![](/img/cover-not-exists.png)
BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients
HANNA PELTTARI, CAMILLA SCHALIN-JÄNTTI, JOHANNA AROLA, ELIISA LÖYTTYNIEMI, SAKARI KNUUTILA, MATTI J. VÄLIMÄKIVolume:
120
Year:
2012
Language:
english
Pages:
7
DOI:
10.1111/j.1600-0463.2011.02844.x
File:
PDF, 85 KB
english, 2012